Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Maj

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Acta Haematologica Polonica|July 1, 1981
[Treatment of acute leukemias in adults. V. The effect of intrathecal cytostatic therapy on leukemic changes in the central nervous system]K Swencz-Szczepanik, S Pawelski, S Maj, et al.
Acta Haematologica Polonica|October 1, 1977
[Analysis of 300 cases of secondary pancytopenia]S Maj, A Janowska-Wieczorek, B Leszko, et al.
Acta Biochimica Polonica|November 20, 1998
Contents of total and protein-bound carbohydrates are low in leukemic leukocytes from patients with acute myelogenous leukemiaG Smoleńska-Sym, E Zdebska, E Gołaszewska, et al.
Acta Haematologica Polonica|January 1, 1991
[Preliminary results of the treatment of acute leukemia with mitoxantrone]T Rozmysłowicz, G Pałynyczko, J Mazur, et al.
Acta Haematologica Polonica|January 1, 1991
[Chemotherapy and immunomodulating treatment of patients with multiple myeloma]M Kraj, A Dmoszyńska, S Maj, et al.
Neoplasma|February 14, 2003
The treatment of acute myeloid leukemia with mitoxantrone, etoposide and low-dose cytarabine in elderly patients - a report of Polish Acute Leukemia Group (PALG) phase II studyA Wrzesien-Kus, T Robak, K Jamroziak, et al.
European Journal of Haematology|August 22, 2003
A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG)A Wrzesień-Kuś, T Robak, E Lech-Marańda, et al.
Leukemia & Lymphoma|June 1, 1996
2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemiaT Robak, M Błasińska-Morawiec, E Krykowski, et al.
Blood|October 7, 2000
Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trialT Robak, J Z Bloński, M Kasznicki, et al.
Leukemia & Lymphoma|June 1, 1997
Activity of 2-chlorodeoxyadenosine (Cladribine) in 2-hour intravenous infusion in 94 previously treated patients with low grade non-Hodgkin's lymphomaT Róbak, J Gora-Tybor, E Krykowski, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Acta Haematologica Polonica|July 1, 1981
[Treatment of acute leukemias in adults. V. The effect of intrathecal cytostatic therapy on leukemic changes in the central nervous system]K Swencz-Szczepanik, S Pawelski, S Maj, et al.
Acta Haematologica Polonica|October 1, 1977
[Analysis of 300 cases of secondary pancytopenia]S Maj, A Janowska-Wieczorek, B Leszko, et al.
Acta Biochimica Polonica|November 20, 1998
Contents of total and protein-bound carbohydrates are low in leukemic leukocytes from patients with acute myelogenous leukemiaG Smoleńska-Sym, E Zdebska, E Gołaszewska, et al.
Acta Haematologica Polonica|January 1, 1991
[Preliminary results of the treatment of acute leukemia with mitoxantrone]T Rozmysłowicz, G Pałynyczko, J Mazur, et al.
Acta Haematologica Polonica|January 1, 1991
[Chemotherapy and immunomodulating treatment of patients with multiple myeloma]M Kraj, A Dmoszyńska, S Maj, et al.
Neoplasma|February 14, 2003
The treatment of acute myeloid leukemia with mitoxantrone, etoposide and low-dose cytarabine in elderly patients - a report of Polish Acute Leukemia Group (PALG) phase II studyA Wrzesien-Kus, T Robak, K Jamroziak, et al.
European Journal of Haematology|August 22, 2003
A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG)A Wrzesień-Kuś, T Robak, E Lech-Marańda, et al.
Leukemia & Lymphoma|June 1, 1996
2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemiaT Robak, M Błasińska-Morawiec, E Krykowski, et al.
Blood|October 7, 2000
Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trialT Robak, J Z Bloński, M Kasznicki, et al.
Leukemia & Lymphoma|June 1, 1997
Activity of 2-chlorodeoxyadenosine (Cladribine) in 2-hour intravenous infusion in 94 previously treated patients with low grade non-Hodgkin's lymphomaT Róbak, J Gora-Tybor, E Krykowski, et al.
Pageof 6